Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Spine|August 28, 2003
Efficacy and safety of rofecoxib in patients with chronic low back pain: results from two 4-week, randomized, placebo-controlled, parallel-group, double-blind trialsNathaniel Katz, William D Ju, David A Krupa, et al.
BMC Neurology|December 7, 2016
Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety studyAaron I Vinik, Serge Perrot, Etta J Vinik, et al.
Scandinavian Journal of Pain|August 30, 2017
A randomized study to evaluate the analgesic efficacy of a single dose of the TRPV1 antagonist mavatrep in patients with osteoarthritisArthur J Mayorga, Christopher M Flores, Jeremiah J Trudeau, et al.
Pain Medicine (Malden, Mass.)|July 31, 2019
Long-term Safety and Tolerability of NKTR-181 in Patients with Moderate to Severe Chronic Low Back Pain or Chronic Noncancer Pain: A Phase 3 Multicenter, Open-Label, 52-Week Study (SUMMIT-08 LTS)Jeffrey Gudin, Richard Rauck, Charles Argoff, et al.
The Journal of Pain|June 24, 2020
Systematic Review of Research Methods and Reporting Quality of Randomized Clinical Trials of Spinal Cord Stimulation for PainEwan McNicol, McKenzie Ferguson, Kathleen Bungay, et al.
Pain|June 14, 2024
A randomized, placebo-controlled trial of long-acting dexamethasone viscous gel delivered by transforaminal injection for lumbosacral radicular painAlan Miller, Kenneth D Candido, Nebojsa Nick Knezevic, et al.
Pain|January 20, 2021
Research design considerations for randomized controlled trials of spinal cord stimulation for pain: Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials/Institute of Neuromodulation/International Neuromodulation Society recommendationsNathaniel Katz, Robert H Dworkin, Richard North, et al.
Pageof 7